Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Scheinberg

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Blood|May 15, 1995
Specific binding of leukemia oncogene fusion protein peptides to HLA class I moleculesM Bocchia, P A Wentworth, S Southwood, et al.
Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemiaK S Kolbert, K A Hamacher, J G Jurcic, et al.
Blood|April 15, 1991
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combinationR M Lemoli, C Gasparetto, D A Scheinberg, et al.
Blood|October 25, 2001
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemiaJ G Jurcic, S D Nimer, D A Scheinberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Chimeric and humanized antibodies with specificity for the CD33 antigenM S Co, N M Avdalovic, P C Caron, et al.
Biochemical and Biophysical Research Communications|January 13, 1997
Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brainJ P Mathis, J Ryan-Moro, A Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Bone marrow dosimetry: regional variability of marrow-localizing antibodyG Sgouros, I M Jureidini, A M Scott, et al.
Blood|December 1, 1994
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acidL Vahdat, P Maslak, W H Miller, et al.
Leukemia|September 20, 2017
A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodiesE Casey, S Bournazos, G Mo, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Blood|May 15, 1995
Specific binding of leukemia oncogene fusion protein peptides to HLA class I moleculesM Bocchia, P A Wentworth, S Southwood, et al.
Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemiaK S Kolbert, K A Hamacher, J G Jurcic, et al.
Blood|April 15, 1991
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combinationR M Lemoli, C Gasparetto, D A Scheinberg, et al.
Blood|October 25, 2001
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemiaJ G Jurcic, S D Nimer, D A Scheinberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Chimeric and humanized antibodies with specificity for the CD33 antigenM S Co, N M Avdalovic, P C Caron, et al.
Biochemical and Biophysical Research Communications|January 13, 1997
Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brainJ P Mathis, J Ryan-Moro, A Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Bone marrow dosimetry: regional variability of marrow-localizing antibodyG Sgouros, I M Jureidini, A M Scott, et al.
Blood|December 1, 1994
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acidL Vahdat, P Maslak, W H Miller, et al.
Leukemia|September 20, 2017
A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodiesE Casey, S Bournazos, G Mo, et al.
Pageof 13